1. Perlman EJ. Pediatric renal tumors: practical
updates for the pathologist. Pediatr Dev Pathol. 2005;8(3):320-338.
2. Bernstein LLM, Smith MA, Olshan AF. Renal tumors. In Ries
LAG, Smith MA, Gurney JG, eds. Cancer Incidence and Survival among
Children and Adolescents: United States SEER Program 1975–1995. Bethesda,
MD: National Cancer Institute, SEER Program, NIH Publ No 99-4649;
1999:79-90.
3. Breslow N, Olshan A, Beckwith JB, et al. Ethnic variation
in the incidence, diagnosis, prognosis, and follow-up of children
with Wilms’ tumor. J Natl Cancer Inst.
1994;86(1):49-51.
4. Breslow N, Olshan A, Beckwith B, et al. Epidemiology of Wilms
tumor. Med Pediatr Oncol. 1993;21(3):172-181.
5. Miller RW, Fraumeni JF Jr, Manning MD. Association of Wilms’s
tumor with aniridia, hemihypertrophy and other congenital malformations.
N
Engl J Med. 1964;270:922-927.
[PubMed: 14114111]
6. Rivera MN, Haber DA. Wilms’ tumour: connecting tumorigenesis
and organ development in the kidney. Nat Rev Cancer. 2005;5(9):699-712.
7. Wilms M. Die Mischgeschwilste. A Georgi
Leipzig; 1899:1-90.
8. Knudson AG Jr, Strong LC. Mutation and cancer: a model for
Wilms’ tumor of the kidney. J Natl Cancer Inst. 1972;48(2):313-324.
9. Knudson AG Jr. Introduction to the genetics of primary renal
tumors in children. Med Pediatr Oncol. 1993;21(3):193-198.
10. Kreidberg JA, Sariola H, Loring JM, et al. WT-1 is required
for early kidney development. Cell. 1993;74(4):679-691.
11. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations
in the Wilms’ tumor suppressor gene are associated with
abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67(2):437-447.
12. Barbaux S, Niaudet P, Gubler MC, et al. Donor splice-site
mutations in WT1 are responsible for Frasier syndrome. Nat
Genet. 1997;17(4):467-470.
13. Reeve AE, Sih SA, Raizis AM, et al. Loss of allelic heterozygosity
at a second locus on chromosome 11 in sporadic Wilms’ tumor
cells. Mol Cell Biol. 1989;9(4):1799-1803.
14. Schroeder WT, Chao LY, Dao DD, et al. Nonrandom loss of
maternal chromosome 11 alleles in Wilms tumors. Am J Hum
Genet. 1987;40 (5):413-420.
15. Koesters R, Adams V, Betts D, et al. Human eukaryotic initiation
factor EIF2C1 gene: cDNA sequence, genomic organization, localization
to chromosomal bands 1p34-p35, and expression. Genomics. 1999;61(2):210-218.
16. Rivera MN, Kim WJ, Wells J, et al. An X chromosome gene,
WTX, is commonly inactivated in Wilms tumor. Science. 2007;315(5812):642-645.
17. Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity
for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology
Wilms tumor: a report from the National Wilms Tumor Study Group. J
Clin Oncol. 2005;23(29):7312-7321.
18. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired
mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer
Res. 1999;59 (1):74-79.
19. Biegel JA. Molecular genetics of atypical teratoid/rhabdoid
tumor. Neurosurg Focus. 2006;20 (1):E11.
20. Taylor MD, Gokgoz N, Andrulis IL, et al. Familial posterior
fossa brain tumors of infancy secondary to germline mutation of
the hSNF5 gene. Am J Hum Genet. 2000;66(4):1403-1406.
21. Fruhwald MC, Hasselblatt M, Wirth S, et al. Non-linkage
of familial rhabdoid tumors to SMARCB1 implies a second locus for
the rhabdoid tumor predisposition syndrome. Pediatr Blood
Cancer. 2006;47(3):273-278.
22. Owens CM, Veys PA, Pritchard J, et al. Role of chest computed
tomography at diagnosis in the management of Wilms’ tumor:
a study by the United Kingdom Children’s Cancer Study Group. J
Clin Oncol. 2002;20(12):2768-2773.
23. Gylys-Morin V, Hoffer FA, Kozakewich H, et al. Wilms tumor
and nephroblastomatosis: imaging characteristics at gadolinium-enhanced
MR imaging. Radiology. 1993;188(2):517-521.
24. Kaste S, Dome J. Wilm’s Tumor, in Practical
Pediatric PET Imaging. New York: Springer; 2006;256-266.
25. Coppes MJ, Zandvoort SW, Sparling CR, et al. Acquired von
Willebrand disease in Wilms’ tumor patients. J
Clin Oncol. 1992;10(3):422-427.
26. Blanchette V, Coppes MJ. Routine bleeding history and laboratory
tests in children presenting with a renal mass.
Pediatr
Blood Cancer. 2009; 52(3):314-315.
[PubMed: 19061220]
27. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse
anaplasia in Wilms tumor—new definitions with prognostic
significance: a report from the National Wilms Tumor Study Group. Am
J Surg Pathol. 1996;20(8):909-920.
28. Spreafico F, Terenziani M, Fossati-Bellani F, et al. Revised
SIOP working classification of renal tumors of childhood.
Med
Pediatr Oncol. 2003;41(1):102.
[PubMed: 12764768]
29. Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration
of preoperative therapy in unilateral and nonmetastatic Wilms’ tumor
in children older than 6 months: results of the Ninth International Society
of Pediatric Oncology Wilms’ Tumor Trial and Study. J
Clin Oncol. 2001;19(2):488-500.
30. D’Angio GJ. Pre- or post-operative treatment for
Wilms tumor? Who, what, when, where, how, why—and which. Med
Pediatr Oncol. 2003;41(6):545-549.
31. D’Angio GJ. The National Wilms Tumor Study: a 40
year perspective.
Lifetime Data Anal. 2007; 13:463-470.
[PubMed: 18027087]
32. Metzger ML, Dome JS. Current therapy for Wilms’ tumor. Oncologist. 2005;10(10):815-826.
33. Grundy P, Breslow N, Green DM, et al. Prognostic factors
for children with recurrent Wilms’ tumor: results from
the Second and Third National Wilms’ Tumor Study. J
Clin Oncol. 1989;7(5):638-647.
34. Green DM, Cotton CA, Malogolowkin M, et al. Treatment of
Wilms tumor relapsing after initial treatment with vincristine and
actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr
Blood Cancer. 2007;48(5):493-499.
35. Malogolowkin M, Cotton CA, Green DM, et al. Treatment of
Wilms tumor relapsing after initial treatment with vincristine,
actinomycin D, and doxorubicin. A report from the National Wilms
Tumor Study Group. Pediatr Blood Cancer. 2008;50(2):236-241.
36. McNeil DE, Brown M, Ching A, et al. Screening for Wilms
tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes:
a cost-effective model.
Med Pediatr Oncol. 2001;
37(4):349-356.
[PubMed: 11568898]
37. Green DM, Breslow NE, Beckwith JB, et al. Screening of children
with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome
in patients with Wilms tumor: a report from the National Wilms Tumor
Study. Med Pediatr Oncol. 1993;21(3):188-192.